List of Sunesis Pharmaceuticals Inc patents

Patent 6878743 was granted and assigned to Sunesis Pharmaceuticals Inc on April, 2005 by the United States Patent and Trademark Office.

Patent 7202033 was granted and assigned to Sunesis Pharmaceuticals Inc on April, 2007 by the United States Patent and Trademark Office.

Patent 7214487 was granted and assigned to Sunesis Pharmaceuticals Inc on May, 2007 by the United States Patent and Trademark Office.

Patent 7314938 was granted and assigned to Sunesis Pharmaceuticals Inc on January, 2008 by the United States Patent and Trademark Office.

Patent 7122687 was granted and assigned to Sunesis Pharmaceuticals Inc on October, 2006 by the United States Patent and Trademark Office.

Patent 9469635 was granted and assigned to Sunesis Pharmaceuticals Inc on October, 2016 by the United States Patent and Trademark Office.

Patent 9676774 was granted and assigned to Sunesis Pharmaceuticals Inc on June, 2017 by the United States Patent and Trademark Office.

Patent 9969730 was granted and assigned to Sunesis Pharmaceuticals Inc on May, 2018 by the United States Patent and Trademark Office.

Patent 9980949 was granted and assigned to Sunesis Pharmaceuticals Inc on May, 2018 by the United States Patent and Trademark Office.

Patent 8138202 was granted and assigned to Sunesis Pharmaceuticals Inc on March, 2012 by the United States Patent and Trademark Office.

Patent 8124773 was granted and assigned to Sunesis Pharmaceuticals Inc on February, 2012 by the United States Patent and Trademark Office.

Patent 9839630 was granted and assigned to Sunesis Pharmaceuticals Inc on December, 2017 by the United States Patent and Trademark Office.

Patent 7601725 was granted and assigned to Sunesis Pharmaceuticals Inc on October, 2009 by the United States Patent and Trademark Office.

Patent 9757363 was granted and assigned to Sunesis Pharmaceuticals Inc on September, 2017 by the United States Patent and Trademark Office.

Patent 7989468 was granted and assigned to Sunesis Pharmaceuticals Inc on August, 2011 by the United States Patent and Trademark Office.

Patent 8822493 was granted and assigned to Sunesis Pharmaceuticals Inc on September, 2014 by the United States Patent and Trademark Office.

Patent 8802719 was granted and assigned to Sunesis Pharmaceuticals Inc on August, 2014 by the United States Patent and Trademark Office.

Patent 10107798 was granted and assigned to Sunesis Pharmaceuticals Inc on October, 2018 by the United States Patent and Trademark Office.

Patent 9724338 was granted and assigned to Sunesis Pharmaceuticals Inc on August, 2017 by the United States Patent and Trademark Office.

Patent 7132568 was granted and assigned to Sunesis Pharmaceuticals Inc on November, 2006 by the United States Patent and Trademark Office.

Patent 8765954 was granted and assigned to Sunesis Pharmaceuticals Inc on July, 2014 by the United States Patent and Trademark Office.

Patent 8778977 was granted and assigned to Sunesis Pharmaceuticals Inc on July, 2014 by the United States Patent and Trademark Office.

Patent 8580814 was granted and assigned to Sunesis Pharmaceuticals Inc on November, 2013 by the United States Patent and Trademark Office.

Patent 8470817 was granted and assigned to Sunesis Pharmaceuticals Inc on June, 2013 by the United States Patent and Trademark Office.

Patent 7115652 was granted and assigned to Sunesis Pharmaceuticals Inc on October, 2006 by the United States Patent and Trademark Office.